The Board has determined that additional development is necessary to determine the cause of the Veteran's myelodysplastic syndrome, including whether it was caused by Agent Orange exposure.
The deciding factor: The medical opinion provided did not adequately address the etiology of the Veteran’s myelodysplastic syndrome and its relation to service, particularly regarding Agent Orange exposure.
- Claimed conditions
- myelodysplastic syndrome (MDS)
- How they argued it
- Not specified
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- June 13, 2019
- Citation
- 19145642
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the appeal for a new VA medical opinion regarding the etiology of the Veteran's MDS and potential AML and b-cell leukemia due to inadequacies in previous opinions.
- Granted
The Board granted service connection for myelodysplastic syndrome (MDS), to include anaplastic anemia, due to toxic exposure at Fort McClellan.
- Granted
The Board granted service connection for myelodysplastic syndrome based on the Veteran's exposure to contaminated water at Camp Lejeune during his military service.
- Denied
The Board denied service connection for myelodysplastic syndrome (MDS) as it was not shown to be related to the Veteran's service or any toxic exposure.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.